GABRP has been reported to play an immunomodulatory role in pancreatic cancer in a neurotransmitter independent manner, promoting macrophage infiltration by inducing the expression of CXCL5 and CCL20, and thereby affecting tumor growth and metastasis (Jiang et al., 2019). The gene discussed is GABRP; the disease is pancreatic neoplasm.